| Pharmaceutical Business | Generic and branded pharmaceuticals including tablets, capsules, injectables, nasal sprays, soft gels. | Strong ANDA portfolio, regulatory approvals (USFDA, MHRA), global manufacturing footprint, strategic partnerships. | Global B2B and B2C including hospitals, pharmacies, governments. | Specialty injectables, controlled substances, and nasal sprays. | 405112 | 100 | Product sales in regulated and emerging markets, licensing, and partnerships. | Direct sales, contract manufacturing, and licensing agreements. | New product launches, regulatory approvals, US and Emerging market expansion. | Jointflex, Fergon, Vanquish |
